For most people new to peptide therapy, a provider will recommend a gentler, lower-risk option first
Tnnies, T., Schlesinger, S., Lang, A
Used appropriately, they can complement GLP-1 therapy and support overall resilience
Gallbladder complications including cholelithiasis (gallstone formation) have emerged as a dose-related risk, particularly with rapid weight loss exceeding 1.5 pounds weekly
Smoking also may impair the phase II metabolites, thus creating more estrogen quinone metabolites with a decreased ability to eliminate them.[ref][ref] Therefore, the combo of variants in phase I and phase II genes (genotype report below) with smoking causes a fairly large increase in the risk of cervical, breast, or prostate cancer